Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01103141 · ClinicalTrials.gov registry record · NA
Femoral Micropuncture or Routine Introducer Study
A NA study, sponsored by Cook Group Incorporated.
- Terminated
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT01103141 is a NA study that was terminated before completion, run by Cook Group Incorporated. The registered enrollment target is 143 participants.
The verdict
NCT01103141, a NA study, was terminated before completion, sponsored by Cook Group Incorporated.
- TERMINATED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
FEMORIS is a marketing study approved by institutional review boards to compare the rates of complications found when using either the Micropuncture® needle introducer or a standard gauge-18 needle to access the groin blood vessels.
Interventions
- DEVICE Micropuncture needle set
- DEVICE Standard gauge-18 needle set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01103141
The ClinicalTrials.gov registry entry for NCT01103141 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Micropuncture needle set is the first listed.
NCT01103141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01103141 about?
NCT01103141 is a clinical study titled "Femoral Micropuncture or Routine Introducer Study". FEMORIS is a marketing study approved by institutional review boards to compare the rates of complications found when using either the Micropuncture® needle introducer or a standard gauge-18 needle to access the groin blood vessels.
What is the current status of trial NCT01103141?
This trial is currently terminated. It is a NA study. The enrollment target is 143 participants. The study started on 2010-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01103141?
The interventions under investigation include: Micropuncture needle set (DEVICE), Standard gauge-18 needle set (DEVICE).
Who is sponsoring clinical trial NCT01103141?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.